New Delhi: “Quality should not be tested in product but it should be built into the product” said Dr. Rubina Bose, Deputy Drugs Controller (India), CDSCO (WZ), Ministry of Health & Family Welfare, Govt. of India.Health and Pharmaceuticals Manufacturing & Medical Devices Committee in association with Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India organized a webinar on Scope of WHO-GMP Certification in Pharmaceutical Industry & Government support. The Guests of Honour of the session were Dr. Rubina Bose, Deputy Drugs Controller (India), CDSCO (WZ), Ministry of Health & Family Welfare, Govt. of India & Prof. Ramesh Goyal, Vice Chancellor, Delhi Pharmaceutical Science & Research University. The other eminent Panellists of the session were Mr. Pradeep Multani, Senior Vice President, PHDCCI, Mr. MukeshSinha, Advisor, Technical, Modi Mundi Pharma, Dr. D P Ghosh, Corporate Head, Technical & Scientific, Albert & David Limited, Dr. Ghulam Moinuddin, Team Lead, Freyr Solutions, Dr. Harvider Popli, Co-Chair, Health Committee, PHDCCI & Director, School of Pharmaceutical Science, DPSRU and the Session was moderated by Mr. Vivek Seigell, Assistant Secretary General, PHDCCI & Dr. Ravi Rathod, Deputy Secretary, PHDCCI. While giving welcome remarks, Mr. Multani said that the GMP guidelines are designed to minimize the risk involved in any pharmaceutical production that cannot be eliminated through testing the finished product Dr. Rubina Bose thanked PHDCCI for gathering all the stakeholders on one platform through this webinar and said that CDSCO ensured the availability of medicines during the covid times by giving approvals to various industry without compromising on quality of products. Dr. D P Ghosh said that for pharmaceutical products, Quality, Efficacy and Safety are the key words. GMP as per requirement of WHO needs updating according WHO Guidelines which gets updated and modified through the TRS. He further said that all related to the Industry should be imparted training on regular intervals by industry experts and senior regulators. Mr. Mukesh Sinha shared his views about importance of WHO-GMP certification in the pharmaceuticals Industry. He also mentioned about significance and need of maintaining data integrity for delivering consistent quality of the products. He also urged for various training programs/ sessions to be conducted for the Industry about WHO-GMP certification.Dr. Ghulam Moinuddin thanked CDSCO for tremendous work done by them during the COVID times and said that regards coming from the world is because, we produce quality drugs starting from the procurement to end product. Dr. Harvider Popli gave a formal vote of thanks and said that there are eight elements of quality manufacturing where ethics and integrity are two basic principals which should be taught and understood during the academics and also at the start of their industry training.
